SUN PHARMACEUTICAL INDUSTRIES INC

SUN PHARMACEUTICAL INDUSTRIES INC: 8 recalls listed since February 2026 across FDA; 1 rated CRITICAL.

By year

20268

By agency

FDA8

By category

Drug8

All recalls (8)

FDA•Aug 18, 2026MODERATE
Carbamazepine Tablets 200mg
Taro recalls Carbamazepine 200mg tablets over black specks.
2 products
FDA•Jun 30, 2026LOW
Fexofenadine Hydrochloride Tablets 180 mg
Ohm Laboratories is recalling 180 mg Fexofenadine Hydrochloride tablets due to failed impurities and degradation specifications.
FDA•Jun 24, 2026MODERATE
Perampanel CIII Tablets
Sun Pharmaceutical is recalling 6mg Perampanel CIII tablets due to a labeling mix-up where bottles may contain 10mg tablets.
FDA•Jun 8, 2026MODERATE
Budesonide Inhalation Suspension
Sun Pharmaceutical is recalling Budesonide Inhalation Suspension (1mg/2mL) due to the presence of foreign black or brown particles.
FDA•Jun 3, 2026MODERATE
Xyvona (levorphanol tartrate) 2mg Tablets
Forte BioPharma recalls Xyvona (levorphanol tartrate) 2mg tablets due to FDA denial of proprietary name.
2 products
FDA•May 13, 2026CRITICAL
DOXOrubicin Hydrochloride Liposome Injection
Sun Pharma recalls DOXOrubicin Liposome Injection 50 mg/25 mL vials due to glass particulate matter.
FDA•Apr 13, 2026MODERATE
Fluocinonide 0.05% Cream 15g
Taro recalls Fluocinonide 0.05% Cream 15g tubes due to out-of-spec viscosity.
3 products
FDA•Feb 11, 2026MODERATE
Diclofenac Sodium Topical Gel 3%
Taro Pharmaceuticals is recalling Diclofenac Sodium Topical Gel 3% (100 g) due to viscosity specification failure.